Centrum 7/6  banner

colchicine tablets USP 0.6 mg.

Aurobindo receives FDA approval for colchicine tablets

Aurobindo receives FDA approval for colchicine tablets

EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application colchicine tablets USP, 0.6 mg. Aurobindo Pharma’s colchicine tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), COLCRYS Tablets, of Takeda Pharmaceuticals USA, Inc. Colchicine tablets are indicated in adults

PP_1170x120_10-25-21